Profile
Ian David Gust is currently the Chairman at Bio21 Australia Ltd. and a Director at Opal Therapeutics, Inc. He is also an Independent Non-Executive Director at Biota Holdings Pty Ltd., a Director at the Australian International Health Institute, a Director at the Pediatric Dengue Vaccine Initiative, and a Professorial Fellow at the University of Melbourne.
In the past, Dr. Gust has worked as the Director of Research & Development at CSL Ltd. from 1990 to 2000.
He was also a Director at the International AIDS Vaccine Initiative, Inc. from 2010 to 2011.
Additionally, he served as a Non-Executive Director at Opal Therapeutics Pty Ltd., McFarlane Burnet Centre For Medical Research, and Aviragen Therapeutics, Inc. Furthermore, he was a Trustee at the International Vaccine Institute in 2006.
Ian Gust active positions
| Companies | Position | Start |
|---|---|---|
| BIOTA HOLDINGS LTD. | Director/Board Member | 26/07/2001 |
Australian International Health Institute | Director/Board Member | 08/02/2011 |
Pediatric Dengue Vaccine Initiative | Director/Board Member | 08/02/2011 |
Bio21 Australia Ltd. | Chairman | 24/01/2012 |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Ian Gust
| Companies | Position | End |
|---|---|---|
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services Develops and distributes vaccines | Director/Board Member | 31/12/2005 |
| CSL LIMITED | Chief Tech/Sci/R&D Officer | 31/12/1999 |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Director/Board Member | - |
McFarlane Burnet Centre For Medical Research | Director/Board Member | - |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Opal Therapeutics, Inc. | |
Biota Holdings Pty Ltd.
Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opal Therapeutics Pty Ltd.
Opal Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for HIV and Hepatitis C & chronic infection | Health Technology |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services Develops and distributes vaccines | Commercial Services |
Australian International Health Institute | |
Pediatric Dengue Vaccine Initiative | |
Bio21 Australia Ltd. | |
McFarlane Burnet Centre For Medical Research | |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Health Technology |
- Stock Market
- Insiders
- Ian Gust
















